Fundz

Who to call at Hologen, and when

Fundz watches for the moments Hologen starts buying, and tells you who to reach.

  • An alert the day Hologen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Hologen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Hologen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Hologen and Sysmex Launch Saibogen, a Joint Venture to Enhance Blood Test Insights with AI.

Nov 09, 2026

Contract Type

partnership

BiotechnologyHealth CareArtificial IntelligenceMedicalMachine Learning

Description

Hologen and Sysmex have announced the formation of Saibogen, a joint venture aimed at transforming routine blood test data into valuable clinical intelligence using AI technologies. This innovative initiative seeks to uncover hidden biological signals within existing data from Sysmex's hematology analyzers, ultimately improving patient care worldwide.

Quick answer

Hologen and Sysmex Launch Saibogen, a Joint Venture to Enhance Blood Test Insights with AI. (November 9, 2026).

What agreement did Hologen announce on November 9, 2026?
Hologen and Sysmex have announced the formation of Saibogen, a joint venture aimed at transforming routine blood test data into valuable clinical intelligence using AI technologies. This innovative initiative seeks to uncover hidden biological signals within existing data from Sysmex's hematology analyzers, ultimately improving patient care worldwide.
What does Hologen do?
Hologen is a frontier medical AI company focused on drug development and diagnostics, as well as investment.
Which similar companies announced agreements around the same time?
Nvidia (November 9, 2026), CGBIO (November 9, 2026), Local Group (November 8, 2026) and Medtronic plc (November 7, 2026) also announced agreements within 45 days of Hologen.

Source: Fundz verified event record.

Other recent agreements in Medical and Biotechnology

Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.

Company Information

Company

Hologen

About

Hologen is a frontier medical AI company focused on drug development and diagnostics, as well as investment. Co-founded by former Google CEO Eric Schmidt, it aims to innovate in personalized medicine by creating large medicine models that recognize biological variations. The company originated from University College London and King’s College London and has already secured initial funding from SW7 and Schmidt. Hologen seeks to revolutionize late-stage clinical trials through advanced AI methodologies.

Predictive Intelligence
Strategic

ML-powered predictions for Hologen's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Hologen signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.